Live Breaking News & Updates on Sales Of Company

Stay updated with breaking news from Sales of company. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

BIOSYNEX Announces the Great Success of Its Capital Increase Through Placement With Qualified Investors for an Amount of €15m


BIOSYNEX Announces the Great Success of Its Capital Increase Through Placement With Qualified Investors for an Amount of €15m
100,00%
For illustration purposes, the participation of a shareholder holding 1% of the Company s share capital prior to the Transaction will be diminished to 0.91%.
ADMISSION TO TRADING OF NEW SHARES
The new shares will bear dividend rights and will be admitted to trading on the Euronext Growth Paris market under the same ISIN code FR0011005933 ALBIO. The settlement and delivery of the new shares and their admission to trading on the Euronext Growth Paris market are scheduled for February 2, 2021.
The information presented in this press release is issued at the end of the placement of the shares by accelerated bookbuilding, which is now closed, but remains conditional on the correct execution of the settlement-delivery operations. ....

United States , France General , United Kingdom , Illkirch Graffenstaden , Gilles Broquelet , Larry Abensur , European Parliament , Meeting Of The Company , Financial Services , Sales Of Company , Regulatory News , Financial Code , General Meeting , Euronext Growth Paris , Rapid Diagnostic Tests , Member States , European Economic Area , Markets Act , Financial Promotion , Financial Promotion Order , Authorized Persons , ஒன்றுபட்டது மாநிலங்களில் , பிரான்ஸ் ஜநரல் , ஒன்றுபட்டது கிஂக்டம் , ஐரோப்பிய பாராளுமன்றம் , சந்தித்தல் ஆஃப் தி நிறுவனம் ,